Aˆbrinolytic protease was puriˆed from an Oriental medicinal herb, Spirodela polyrhiza (Choi, H. S., et al., Biosci. Biotechnol. Biochem., 65, 781-786 (2001)). The protease hydrolyzed not onlyˆbrin but alsoˆbrinogen. The enzyme had an anticoagulant activity measured with activated partial thromboplastin time, thrombin time, and prothrombin time in rat plasma. It doubled all three at 69, 29, and 221 nM, respectively. The protein had anticoagulant activity when given intravenously and orally. The maximum delay in the activated partial thromboplastin time was at the dose of 0.52 and 4.2 mg W kg for intravenous and oral administration, respectively. This protein may be useful in clinical applications for anticoagulation.
Blood clots are formed fromˆbrinogen by thrombin and are lysed by the plasmin system, which is activated from plasminogen by a tissue plasminogen activator. The blood clotting and lysis systems are tightly regulated to maintain homeostasis. An inclination toward coagulation results in serious cardiovascular and cerebral thrombosis. The substances involved in anticoagulation orˆbrinolysis are a promising target for antithrombotic therapy. [1] [2] [3] [4] [5] [6] [7] [8] Activated protein C, a natural coagulation inhibitor, 9) SANORG34006, a synthetic pentasaccharide, 10) aˆbrinolytic enzyme from Bacillus spp. in the traditional Korean and Japanese fermented foods, chungkook-jang 11) and natto, 12) respectively, an anticoagulant, hirudin, from Hirudo medicinalis, 13) brinolytic proteases from Pleurotus ostreatus, 14) Flammulina velutipes, 15) Ganoderma lucidum, 16) and Spirodela polyrhiza 17) have been reported and characterized. S. polyrhiza is an ingredient of traditional Oriental medicines. It has been used for lowering blood pressure and detoxiˆcation of snake venom. Previously aˆbrinolytic protease was puriˆed and characterized from S. polyrhiza.
17) The protein was administered in rats intravenously or orally and it showed anticoagulant activity in vivo. This protein could be useful in clinical applications for reducing thrombosis.
A protease was puriˆed from S. polyrhiza by the method of Choi and Sa. 17) Fractions containinĝ brinolytic protease activity were concentrated and exchanged with phosphate based saline by ultraˆltra-tion using a PM 10 membrane. An ex vivo coagulation assay was done in male Spargue-Dawley rats (300 g). The protease from S. polyrhiza was injected into the rat's femoral vein with pentobarbital anesthesia (35 mg W kg, i.p.) at one of several concentrations (0.050, 0.26, and 0.52 mg W kg). A control rat received the same volume of saline. The abdomens of the rats were opened and the vena cava was exposed. Blood (0.9 ml) was taken from the aorta into a plastic syringe containing 0.1 volume of 3.8z sodium citrate, and plasma was prepared by centrifugation. The protein was also administered to rats by the oral route (gavage) at the concentrations 1.2, 2.0, and 4.2 mg W kg. Blood was withdrawn from the tail vein of each rat into a vial containing sodium citrate, which was gently mixed before centrifugation. The activated partial thromboplastin time (APTT) was measured by the increase of absorbance at 420 nm by the method of Choi and Sa. 17) A typical assay for APTT contained 0.25 ml plasma and 0.25 ml APTT reagent in aˆnal volume of 0.5 ml. The reaction mixture was incubated at 379 C for 2 min and the reaction was started by adding 4 ml of 1 M CaCl2. A coagulation assay was done using fresh normal rat blood. Blood was taken from the aorta, plasma was prepared with an initial whole blood centrifugation at 400×g for 10 min, and a second centrifugation of the plasma at 800×g for 20 min to remove residual platelets. APTT, the thrombin time (TT), and the prothrombin time (PT) were measured by the increase of The eŠects of Spirodela protease on TT (ˆlled circles), APTT (empty circles), and PT (ˆlled squares) were measured and data was expressed as the mean±SD. Each set of assays was done in rat plasma from a single rat. The clotting time (APTT) was measured after diŠerent concentrations (0.050 mg W kg,ˆlled circles; 0.26 mg W kg, empty circles; 0.52 mg W kg,ˆlled squares) of the protease were administered intravenously to rats. APTT was measured at 379 C by the increase in the absorbance at 420 nm. Three sets of experiments were done; these results are typical. The clotting time (APTT) was measured after diŠerent concentrations (1.2 mg W kg,ˆlled circles; 2.0 mg W kg, empty circles; 4.2 mg W kg,ˆlled squares) of the protease were administered orally to rats. APTT was measured at 379 C by the increase in the absorbance at 420 nm. Two sets of experiments were done; these results are typical.
absorbance at 420 nm. 17) Theˆbrinolytic protease from S. polyrhiza delayed TT, APTT, and PT in rat plasma (Fig. 1) . TT was more sensitive than APTT and PT. TT was prolonged to 2 and 3 times the control value at approximately 29 and 38 nM, respectively. The control TT was 30±3.1 seconds. Compared with its eŠect on TT, the enzyme induced a more gradual delay of APTT. APTT required 69 nM to reach 2 times the control value (25±0.0 seconds). PT was prolonged to twice the control value at 221 nM. As a control, heparin prolonged clotting times twice at 2.1 and 3.8 mM for APTT and TT, respectively. The anticoagulant activity of S. polyrhiza protease was stronger than that of heparin in terms of concentration. Delays of APTT and PT were less sensitive in rat plasma than in human plasma, except that of TT.
17) The protein was injected i.v. or orally into rats to investigate whether it also showed anticoagulation activity in vivo. When the coagulation assay was done ex vivo, the maximum delay in APTT was at the dose of 0.52 mg W kg when intravenously injected (Fig. 2) . After administration, the delay occurred immediately and dropped to a normal level at the concentration of 0.050 and 0.26 mg W kg of S. polyrhiza protease. However, the remaining delay occurred by 2 h after injection of protein at a high concentration. When orally injected into rats, S. polyrhiza protease also prolonged APTT at much higher concentrations (Fig. 3) . The normal clotting time in rats is 30±2.0 sec. APTT increased abruptly after 3-6 h following oral administration. The delay in clotting time lasted even after 102 h of administration at the 4.2 mg W kg concentration. The biological activity can be compared with the results observed after intravenous administration. Oral administration required much higher dosages, probably due to denaturation of protein, but duration periods were longer than i.v. injection in rats. A previous study 17) has suggested that the anticoagulation activity of S. polyrhiza protein could be due to not only itsˆbrino-lytic activity, but also antithrombotic activity. This protein showed anticoagulant activity ex vivo as well as in vitro in the rat model. This protein may be useful in clinical applications for anticoagulant activity.
